Neurosterix
Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.
$105M Series B+ ·
Led by RTW Investments · Source: citybiz.co
Total raised: $168M across 2 sourced rounds
All 2 rounds ↓Signals
X account@neurosterix · created May 11, 2024 (2 years old) · 20 followers
TIMELINE · MONEY RAISED
Neurosterix | 956 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $105M | citybiz.co | ||
| Series A | $63M | xontogeny.com |
Timeline
- X account created
Founders and team
FC
Fred Callori CEO, Co-Founder, Board of DirectorsLinkedIn · source: neurosterix.comMK
Mikhail Kalinichev Head of Translational Science
Investors
AAcorn Bioventures
- AAddex Therapeutics
PPerceptive Advisorslead investor
RRTW Investmentslead investor
XXontogeny
Companies like Neurosterix
DDraig Therapeutics$65M Series B+ · Jul 2026
EEngrail Therapeutics$157M Series B+ · Mar 2024
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
NNavega TherapeuticsSeries A · Nov 2024
VVerdiva Bio$410M Series A · Jan 2025
RResalis Therapeutics$10.92M Series A · Jan 2024
Other companies backed by RTW Investments
CCorxel$287M Series B+ · Jan 2026MMirador Therapeutics$250M Series B+ · Jan 2026
UUmoja Biopharma$100M Series B+ · Jan 2025
EEnsoma$50M Series B+ · May 2023
WWindward BioSeries A · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neurosterix (get a free API key).